Lucid Diagnostics (LUCD) Treasury Shares (2021 - 2026)

Lucid Diagnostics has reported Treasury Shares for 6 years, with the latest figure at $12.3 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 86.74% year-over-year to $12.3 million; the trailing twelve-month figure through Mar 2026 stood at $12.3 million (up 86.74% YoY), and the FY2025 full-year result was $6.6 million, up 68.94% from the prior year.
• Treasury Shares for Q1 2026 stood at $12.3 million, up from $6.6 million in the prior quarter.
• The five-year high for Treasury Shares was $12.3 million in Q1 2026, with the low at $1.8 million in Q3 2023.
• Historically, Treasury Shares has averaged $4.1 million across 5 years, with a median of $2.3 million in 2023.
• Annual changes were most pronounced in 2023 — Treasury Shares dropped 17.19% — and 2025, when it soared 186.59%.
• Lucid Diagnostics' Treasury Shares stood at $2.1 million in 2022, then climbed by 11.76% to $2.3 million in 2023, then surged by 66.74% to $3.9 million in 2024, then soared by 68.94% to $6.6 million in 2025, then surged by 86.74% to $12.3 million in 2026.
• The last three Treasury Shares figures came in at $12.3 million (Q1 2026), $6.6 million (Q4 2025), and $6.6 million (Q3 2025), per Business Quant data.